1-7 of 7
Andrey Garifullin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Prognostic Significance of Minimal Residual Disease in Multiple Myeloma in the Molecular Genetic Groups Msmart 3.0

Andrey Garifullin, MD, Sergei Voloshin, MD PhD, Sergey Linnikov, Irina Martynkevich, MD PhD, Alexey Kuvshinov, MD, Anastasiya Kuzyaeva, Zhanna Chubukina, Vasily Shuvaev, MD, Elizaveta Kleina, Marina Bakai, Alexander Sсhmidt
Journal: Blood
Blood (2020) 136 (Supplement 1): 42.
https://doi.org/10.1182/blood-2020-139239
Published: 2020
Journal Articles

The Comparison of Results of Autologous Transplantation Using Non-Cryopreserved and Cryopreserved Hematopoietic Stem Cells (HSC)

Sergei Voloshin, MD PhD, Andrey Garifullin, MD, Sergey Linnikov, Anastasiya Kuzyaeva, Vasily Shuvaev, MD, Valentina Balashova, Georgiy Rysev, MD, Alexander Chechetkin, MD PhD, Zanna Chebukina
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-142279
Published: 2020
Journal Articles

Short-Term Noncryopreserved Hematopoietic Stem Cells: Single Center Experience of Autologous Transplantation

Sergei Voloshin, MD PhD, Andrey Garifullin, MD, Anastasiya Kuzyaeva, Vasily Shuvaev, MD, Alexander Schmidt, Alexey Kuvshinov, MD, Valentina Balashova, Zhanna Chubukina, Elena Belyakova, MD, Georgiy Rysev, MD, Alexander Chechetkin, Viktor Rugal'
Journal: Blood
Blood (2019) 134 (Supplement_1): 5636.
https://doi.org/10.1182/blood-2019-131695
Published: 2019
Journal Articles

Significance of Modified Risk Stratification Msmart 3.0 and Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma

Andrey Garifullin, MD, Sergei Voloshin, MD PhD, Vasily Shuvaev, MD, Irina Martynkevich, MD PhD, Elizaveta Kleina, Alexander Chechetkin, Stanislav Bessmeltcev, Anastasiya Kuzyaeva, Alexander Sсhmidt, Alexey Kuvshinov, MD, Irina Pavlova
Journal: Blood
Blood (2019) 134 (Supplement_1): 5593.
https://doi.org/10.1182/blood-2019-130092
Published: 2019
Journal Articles

Maintenance Therapy in Patients with Chronic Lymphocytic Leukemia Who Achieved MRD-Positive Remissions after Induction Therapy

Alexey Kuvshinov, MD, Sergei Voloshin, MD PhD, Vasily Shuvaev, MD, Elena Belyakova, MD, Mariia Mikhaleva, MD, Andrey Garifullin, MD, Georgiy Rysev, MD, Alexander Bogdanov, MD PhD, Irina Martynkevich, MD PhD, Elizaveta Kleina, Alena Samorodova, MD, Iuliia Ruzhenkova, Iuliia Vokueva, Alexander Chechetkin
Journal: Blood
Blood (2019) 134 (Supplement_1): 5475.
https://doi.org/10.1182/blood-2019-129995
Published: 2019
Journal Articles

The Prognostic Significance of Minimal Residual Disease and Possibility of Its Correction in Multiple Myeloma

Andrey Garifullin, MD, Sergei Voloshin, MD PhD, Alexey Kuvshinov, MD PhD, Anastasiya Kuzyaeva, Alexander Sсhmidt, Zhanna Chubukina, Vasily Shuvaev, MD, Evgeniy Krasnikov, Sergey Linnikov
Journal: Blood
Blood (2018) 132 (Supplement 1): 5751.
https://doi.org/10.1182/blood-2018-99-118457
Published: 2018
Journal Articles

The Significance of Flow Cytometry and Positron Emission Tomography and Computed Tomography (PET-CT) in the Assessment of the Minimum Residual Disease in Patients with Multiple Myeloma

Andrey Garifullin, Sergei Voloshin, MD PhD, Alexey Kuvshinov, MD, Alexander Schmidt, Vasily Shuvaev, MD PhD, Yuriy Kryvolapov, Elena Belyakova, Evgeniy Krasnikov, Alexander Chechetkin
Journal: Blood
Blood (2017) 130 (Supplement 1): 3097.
https://doi.org/10.1182/blood.V130.Suppl_1.3097.3097
Published: 2017